Loading
A phase 3 trial of Intraoperative radiotherapy in Glioma & glioblastoma, run by Universitätsmedizin Mannheim, active and no longer recruiting.
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme is a phase 3 interventional study registered as NCT02685605 by Universitätsmedizin Mannheim, with 314 participants planned, started 2016-12-09 and due to reach its primary completion in 2025-11. Interventions recorded: Standard surgery, Intraoperative radiotherapy, Radiochemotherapy, Temozolomide. Conditions recorded: Glioblastoma.
Linked to the technology Intraoperative radiotherapy because the registry names it ("intraoperative radiotherapy") among its interventions and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Intraoperative radiotherapy (IORT) and the tag pipeline.
Shares Intraoperative radiotherapy (IORT) and the tag pipeline.